Senti Biosciences Inc. (SNTI)
NASDAQ: SNTI
· Real-Time Price · USD
2.20
-0.01 (-0.45%)
At close: Jul 03, 2025, 3:33 PM
2.26
2.73%
After-hours: Jul 03, 2025, 04:55 PM EDT
-0.45% (1D)
| Bid | 1.64 |
| Market Cap | 57.38M |
| Revenue (ttm) | 5.86M |
| Net Income (ttm) | -54.79M |
| EPS (ttm) | 0.37 |
| PE Ratio (ttm) | 5.95 |
| Forward PE | -0.99 |
| Analyst | Buy |
| Ask | 2.84 |
| Volume | 113,763 |
| Avg. Volume (20D) | 208,365 |
| Open | 2.21 |
| Previous Close | 2.21 |
| Day's Range | 2.20 - 2.34 |
| 52-Week Range | 1.52 - 16.94 |
| Beta | 2.24 |
About SNTI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SNTI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SNTI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Senti Biosciences Inc. is scheduled to release its earnings on Aug 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
+362.96%
Senti Biosciences shares are trading higher after ...
Unlock content with
Pro Subscription
10 months ago
+10.15%
Senti Biosciences shares are trading higher after the company announced a year-over-year increase in Q2 EPS results.
1 month ago · accessnewswire.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation Into Senti Biosciences IncNEW YORK, NY / ACCESS Newswire / May 29, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Senti Biosciences Inc ("SNTI" or the "Company") (N...
